D.E. Shaw & Co’s ChemoCentryx, Inc. CCXI Stock Holding History

D.E. Shaw & Co’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,900	Closed	-$305K	–	5553
2022 Q3	$305K	Buy	+5,900	New	+$244K	﹤0.01%	4289
2022 Q1	–	Sell	-5,900	Closed	-$215K	–	6173
2021 Q4	$215K	Buy	+5,900	New	+$207K	﹤0.01%	4849

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's CCXI Position: Q4 2022 in Review

D.E. Shaw & Co sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 46,619 shares — an estimated $2.41M sold.

D.E. Shaw & Co first reported a position in CCXI in Q2 2013 and held it in 34 quarters. The position peaked at $43.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

D.E. Shaw & Co reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 46,619 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.41M.
D.E. Shaw & Co first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 34 quarters.
D.E. Shaw & Co's ChemoCentryx, Inc. position peaked at $43.2M in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.